Not yet recruiting
Triple negative breast cancer
Not yet recruitingAssessing the prognostic value of PSMA‑T4 SPECT/CT imaging in patients with triple‑negative breast cancer undergoing neoadjuvant therapy
InvestigationalNo placebo
Assessing the prognostic value of PSMA‑T4 SPECT/CT imaging in patients with triple‑negative breast cancer undergoing neoadjuvant therapy
InvestigationalNo placebo
- Disease:Triple negative breast cancer
- Substances:PSMA-T4
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:PSMA-T4
